Bir Türk Popülasyonunda Preeklampsi ACE Gen Promoter Bölgesinin Rolü

Öz

Anahtar Kelimeler

• ACE2
• preeklampsi
• varyasyon

The Role of The ACE Gene Promoter Region in Preeclampsia in a Turkish Population

Öz

It is known that preeclampsia (PE), a common multisystemic and multifactorial pregnancy disease, causes 10-15% of direct maternal deaths worldwide. Many research, including whole genome sequencing studies, has been and continues to be done in search of a mutant gene that can cause the disease. According to studies, one of the candidate genes associated with PE is ACE2 gene. Therefore, in this study, it was aimed to investigate the variations in the promoter region of ACE2 gene for the first time in a Turkish population. Sequencing analysis was performed on genetic material obtained from maternal blood with samples collected from 60 PE patients and 60 healthy pregnant women with demographic data compatible with the patients. Sequencing analysis was performed with the Sanger sequencing method and ABI 3130XL instrument. According to the results of the sequence analysis, no variation was found in the studied region. However, PE disease remains a major health problem in pregnancy, and accumulating evidence indicates that ACE2 may also have effects on the disease. Therefore, improved structural and functional studies in larger populations are needed to understand these effects.

Anahtar Kelimeler

• ACE2
• preeclampsia
• variation

Kaynakça

1. Referans1:Benjafıeld, A.V., Wang. W.Y.S., Morris, B.J. 2004. No association of Angiotensin-Converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens. 17(7):624-628. doi: 10.1016/j.amjhyper02.22.
2. Referans2:Brosnihan, K.B., Neves, L.A., Anton, L., Joyner, J., Valdes, G., Merrill, D.C. 2004. Enhanced expression of Ang-(1-7) during pregnancy. Braz J Med Biol Res. 37(8):1255-1262. doi: 10.1590/s0100-879x2004000800017.
3. Referans3:Duley, L. 2009. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 33(3):130-137. doi: 10.1053/j.semperi.2009.02.010.
4. Referans4:England, L., Zhang, J. 2007. Smoking and risk of preeclampsia: a systematic review. Front Biosci. 12:2471-2483.
5. Referans5:Fan, Z., Wu, G., Yue, M., Ye, J., Chen, Y., Xu, B. Tan, X. 2019. Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism. Life Sci. 225:39-45. doi: 10.1016/j.lfs.2019.03.059
6. Referans6:Flint, E.J., Cerdeira, A.S., Redman, C.W., Vatish, M. 2019. The role of angiogenic factors in the management of preeclampsia. Acta Obstet Gynecol Scand. 98(6):700-707. doi:10.1111/aogs.13540. Referans7:Hiby, S.E., Walker, J.J., O'shaughnessy, K.M., Redman, C.W., Carrington, M., Trowsdale, J., Moffett, A. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 200(8):957-965.
7. Referans8:Hod, T., Cerdeira, A.S., Karumanchi, S.A. 2015. Molecular Mechanisms of Preeclampsia. Cold Spring Harb Perspect Med. 20;5(10):a023473. doi: 10.1101/cshperspect.a023473. Referans9:James, J.L., Whitley, G.S., Cartwright, J.E. 2010. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol. 221:363–378.
8. Referans10:Luo, Y., Liu, C., Guan, T.,et al. 2019. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang. Hypertension Res. 42(5):681-689. doi:10.1038/s41440-018-0166-6.

9. Referans11:Malard, L., Kakinami, L., O'Loughlin, J., Roy-Gagnon, M.H., Labbe, A., Pilote, L. 2013. The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents. BMC Med Genet; 14:117.
10. Referans12:Merrill, D.C., Karoly, M., Chen, K., Ferrario, C.M., Brosnihan, K.B. 2002. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine. 18:239e45
11. Referans13:Mert, I., Oruc, A.S., Yuksel, S., Cakar, E.S., Buyukkagnici, U., Karaer, A., Danisman, N. 2012. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J Obstet Gynaecol Res. 38(4):658-664. doi:10.1111/j.1447-0756.2011.01771.x.
12. Referans14:Rajakumar, A., Brandon, H.M., Daftary, A., Ness, R., Conrad, K.P. 2004. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta. 25(10):763-769.
13. Referans15:Redman, C.W., Staff, A.C. 2015. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 213(4 Suppl):S9.e1, S9-11. doi:10.1016/j.ajog.08.003.
14. Referans16:Steegers, E.A, von Dadelszen, P, Duvekot, J.J., Pijnenborg, R. 2010. Pre-eclampsia. Lancet. 376:631–44.
15. Referans17:Ullrich, A., Shine, J., Chirgwin, J., 1997. Rat insülin genes: construction of plasmids containing the coding sequences. Science, 196(4296):1313-1319.
16. Referans18:Velkoska, E., Patel, S.K., Burrell, L.M. 2016. Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pres sure regulation. Curr Opin Nephrol Hypertens. 25:384.
17. Referans19:Yang, J., Shang, J., Zhang, S., Li, H. Liu, H. 2013. The role of the renin-angiotensin-aldosterone system in preeclampsia: genetic polymorphisms and microRNA, J. Mol. Endocrinol. 50(2):R53–R66.
18. Referans20:Zhuang, B., Luo, X., Rao, H., Li, Q., Shan, N., Liu, X., Qi, H. 2015. Oxidative stress-induced C/EBPβ inhibits β-catenin signaling molecule involving in the pathology of preeclampsia. Placenta. 36(8):839-46. doi: 10.1016/j.placenta.2015.06.016.